Vyvanse Adds 14-Hour Duration Data As Shire's ADHD Drugs Face Off With Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
Duration of use data will help to strengthen Vyvanse's position in the fast-growing adult segment, Shire says.